Forbes -
24 Aug 2021 16:00

Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around 150,000 as of August 21, up by about 3x over the last month. Pfizer along with its German partner BNTX..
Share this Article